CN101642516A - Ganfukang capsule - Google Patents
Ganfukang capsule Download PDFInfo
- Publication number
- CN101642516A CN101642516A CN200910094627A CN200910094627A CN101642516A CN 101642516 A CN101642516 A CN 101642516A CN 200910094627 A CN200910094627 A CN 200910094627A CN 200910094627 A CN200910094627 A CN 200910094627A CN 101642516 A CN101642516 A CN 101642516A
- Authority
- CN
- China
- Prior art keywords
- capsule
- radix
- ganfukang
- liver
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention provides a Ganfukang capsule, wherein the medicine powder in the capsule is formed by mixing the each dried raw material powder or decoction piece powder in proportions with the following parts by weight: 1.5-2 parts of oriental wormwood, 1-1.5 parts of selfheal, 1-1.5 parts of radix bupleuri, 1-1.5 parts of the dried rhizome of rehmannia, 0.3-0.8 part of wine fried rhizoma coptidis,0.5-1 part of green tangerine orange peel, 1-1.5 pars of milk veteh, 0.3-0.8 part of rhizoma cyperi, elecampane, placenta hominis, angelica, radix paeoniae alba, angelica, radix paeoniae alba, szechuan lovage rhizome, salvia miltiorrhiza, herba cistanche, morinda officinalis, the fruit of Chinese wolfberry, glossy privet fruit, epimedium, Chinese chive seed, eucommia bark, dogwood, semen cuscutae, spina date seed, schisandra chinensis, etc. The capsule is characterized by tonifying the liver and the kidney, enriching the blood and the qi, clearing away heat and detoxifying, soothing the liverand regulating the flow of qi, and soothing liver-qi stagnation, having obvious curative effects for early hepatocirrhosis, fatty liver, alcohol liver, abdominal distention and pain, spontaneous perspiration and night sweat, weariness and hypodynamia, tinnitus and pharyngoxerosis, and the like, which are caused by liver-Qi depression, qi depression and blood stasis, deficiency of kidney-QI and weakness of the spleen and the stomach, and having convenient use and no side effect.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition for the treatment of the human liver disease, Ganfukang capsule.
Background technology
It is very big related that hepatopathy and kidney, spleen have, and liver morbidity spleen also can be sick, and treating the liver is sick wants invigorating the liver and kidney and spleen invigorating, and reinforcement and elimination in combination just can play curative effect.The hepatopathy of some incretion, as fatty liver, alcoholic liver, early stage liver cirrhosis etc. is exactly this situation, modern society, people's living standard improves day by day, and diet is attached undue importance to one thing to the neglect of the other, and causes overnutrition, alcoholism, make the overload operation such as detoxifcation organ liver, kidney, spleen of health, in the course of time, make the functional disorder between each organ, thus morbidity.Treating this type of disease traditional Chinese medical science still is all not effective especially medicine of doctor trained in Western medicine, though kind much all has certain toxic and side effects, particularly Western medicine, toxic and side effects is more obvious.The special-purpose medicine of traditional Chinese medical science molding is not found so far, mostly now opens existing usefulness with doctor's magistral prescription behavior, has nothing in common with each other.People use very inconvenient, and curative effect is also not obvious.
Summary of the invention
Purpose of the present invention is exactly at the problems referred to above, propose diseases such as a kind of fatty liver that causes to early stage liver cirrhosis, because of depression of liver-QI, qi depression to blood stasis, deficiency of kidney-QI, weakness of the spleen and stomach, alcoholic liver, abdominal distention, spontaneous sweating, lassitude and weak, tinnitus dry pharynx obvious curative effects, Chinese medicine composition easy to use are arranged, Ganfukang capsule is to solve the deficiencies in the prior art.
This Ganfukang capsule that the present invention proposes, it is characterized in that in the capsule medicated powder be by following each flavor do former medicated powder or decoction pieces powder by weight mixed form:
Herba Artemisiae Scopariae 1.5-2 part, Spica Prunellae 1-1.5 part, Radix Bupleuri 1-1.5 part, Radix Rehmanniae 1-1.5 part, Rhizoma Coptidis(processed with wine) 0.3-0.8 part, Pericarpium Citri Reticulatae Viride 0.5-1 part, Radix Astragali 1-1.5 part, Rhizoma Cyperi 0.3-0.8 part.
Can add Radix Aucklandiae 0.3-0.5 part successively on this basis, Placenta Hominis 0.5-1 part, Radix Angelicae Sinensis 0.5-1 part, Radix Paeoniae Alba 0.5-1 part, Rhizoma Chuanxiong 0.3-0.8 part;
Radix Salviae Miltiorrhizae 0.5-1 part, Herba Cistanches 1-1.5 part, Radix Morindae Officinalis 1-1.5 part, Fructus Lycii 1-1.5 part, Fructus Ligustri Lucidi 1-1.5 part;
Herba Epimedii 1-1.5 part, Semen Allii Tuberosi 1-1.5 part, Cortex Eucommiae 0.5-0.8 part, Fructus Corni 0.5-0.8 part, Semen Cuscutae 1-1.5 part, Semen Ziziphi Spinosae 0.5-0.8 part, Fructus Schisandrae Chinensis 0.5-0.8 part.
Below respectively the distinguish the flavor of combination collocation of medicine, can be former medicated powder combination, former medicine combination back pulverize or former medicine combination back by boiling the extract powder that the mode of carrying obtains.
Capsule is generally with every 05g dosage dress.Usage and dosage is different according to the state of an illness and age, and Coming-of-Age Day obeys 2-3 time, each 5-6 grain, and the child is cut down according to the circumstance, warm water delivery service.
Characteristics of the present invention are that invigorating the liver and kidney, blood-enriching qi-invigorating, heat-clearing and toxic substances removing, depressed liver-energy dispersing and QI regulating, resolving depression are released vexed, diseases such as the fatty liver that causes to early stage liver cirrhosis, because of depression of liver-QI, qi depression to blood stasis, deficiency of kidney-QI, weakness of the spleen and stomach, alcoholic liver, abdominal distention, spontaneous sweating, lassitude and weak, tinnitus dry pharynx have obvious curative effects, easy to use, have no side effect.
Demonstrate beneficial effect of the present invention below.
The specific embodiment
Case 1, Zhang, the man, 30 years old, Gejiu, the Yunnan cadre of government bodies suffered from hepatitis B in 1996, and was long-term few smart inattentive, inappetence, abdominal distention stomachache checks that to " small three positive " mild is arranged.Begin to take capsule of the present invention in mid-April, 2007, usage and dosage is secondary every day, and each 5, every granule amount is 05g.Continuous use remission after 20 days.Show that through ultrasound diagnosis and chemical examination three positive indexs are kept to one.
This routine capsular medicated powder is formed: 2 parts of Herba Artemisiae Scopariaes, 1 part of Spica Prunellae, 1 part of Radix Bupleuri, 1 part in the Radix Rehmanniae, 0.3 part of Rhizoma Coptidis(processed with wine), 0.5 part on Pericarpium Citri Reticulatae Viride, 1 part of the Radix Astragali, 0.3 part of Rhizoma Cyperi.Be and do former medicated powder.
Herba Artemisiae Scopariae changes 1.5 parts into, all the other each components change above-mentioned interval separately high end value and intermediate value respectively into, and all the other conditions are constant, through a local childhood suffered from jaundice type hepatitis, 26 years old surnamed Zhang man patient takes, the transference cure of its anorexia behind the first quarter moon, uncomfortable in chest and hepatalgia has recovered health.
Case 2, grandson so-and-so, man, 48 years old, nationality Gejiu, Zhejiang businessman.Suffered from hepatitis A in 1999, and do not heal, be converted into hepatitis B in the time of 2004, corresponding symptom occurs through controlling.Take capsule for treating of the present invention in mid-April, 2007, usage and dosage is a day clothes secondary, each 5, and the same example of every granule amount.Taking after 2 months disease continuously greatly alleviates.Through looking into, the positive index of hepatitis B all transfers feminine gender to, has recovered health fully.
This routine capsule medicated powder consists of: example has increased by 0.5 part of the Radix Aucklandiae on 1 Zhang's medication basis, 1 part of Placenta Hominis, 1 part of Radix Angelicae Sinensis, 1 part of the Radix Paeoniae Alba, 0.8 part of Rhizoma Chuanxiong.
Change the Radix Aucklandiae, Placenta Hominis, Radix Angelicae Sinensis, the Radix Paeoniae Alba and Rhizoma Chuanxiong into the low end value and the intermediate value in numerical value interval separately respectively on example 1 Zhang's medication basis, all the other are constant.It is on probation that there is the patient of identical or close disease the position surplus 20, and effect is obvious, and effective percentage is more than 95%.
Example 3, Lee so-and-so, man 47 years old, Luxi County, Yunnan peasant suffers from alcoholic liver because of duration of alcohol consumption is long, shows as vexed few the dormancy, and is listless, inappetence, dyspepsia, myasthenia of limbs.In early Febuary, 2007 begins to take capsule of the present invention.The same example of usage and dosage, serve on 75 days after, transference cure, the patient says that all feel all good.
It is to have increased by 1 part of Radix Salviae Miltiorrhizae on so-and-so medication basis of example 2 grandsons that this routine capsule medicated powder is formed, 1.5 parts of Herba Cistanches, 1.5 parts of Radix Morindae Officinaliss, 1.5 parts of Fructus Lycii, 1.5 parts of Fructus Ligustri Lucidi.
The proportioning of Radix Salviae Miltiorrhizae, Herba Cistanches, Radix Morindae Officinalis, Fructus Lycii and Fructus Ligustri Lucidi is pressed interval separately low end value and intermediate value, and all the other are constant.Use proof through 35 alcoholic liver patients in various degree, curative effect is obvious, effective percentage 97%.
Example 4, virgin so-and-so, man, 53 years old, the workman of Laochang Tin Mine, Yunnan Tin Industry Co..Just suffered from fatty liver in 2000, and long-term abdominal distention, detested oily anorexia, do not have spirit, myasthenia of limbs.Begin to take capsule of the present invention the first tenday period of a month in May, 2006, and usage and dosage is with example 3.Take continuously that disease all disappears after 3 months, do not send out so far.
It is to have increased by 1 part of Herba Epimedii on so-and-so medication basis of example 3 Lee that this routine capsule medicated powder is formed, 1 part of Semen Allii Tuberosi, 0.5 part of the Cortex Eucommiae, 0.5 part of Fructus Corni, 1 part of Semen Cuscutae, 0.5 part of Semen Ziziphi Spinosae, 0.5 part of Fructus Schisandrae Chinensis.
Change the proportioning of Herba Epimedii, Semen Allii Tuberosi, the Cortex Eucommiae, Fructus Corni, Semen Cuscutae, Semen Ziziphi Spinosae and Fructus Schisandrae Chinensis into interval separately high end value and intermediate value respectively, through practicality, curative effect is all obvious.To the effective percentage of fatty liver all more than 80%.
Afterwards the pair relationhip of each component had been done how variant combination adjustment again in the interval range of above-mentioned qualification.Proof is as long as all there is roughly the same curative effect in interval range.Medicated powder is incapsulated with the extractum that boils the mode of putting forward and extract, and curative effect generally shows more obvious, but the effect after having individual patient to take dies down on the contrary, may be through over-cooking due to some peculiar active component disappears after carrying.
More than the age of patient age when taking capsule of the present invention first of each case.The patient all had the history of taking other drug in various degree before taking capsule of the present invention.
Claims (5)
1, this Ganfukang capsule that proposes of the present invention, it is characterized in that in the capsule medicated powder be by following each flavor do former medicated powder or decoction pieces powder by weight mixed form:
Herba Artemisiae Scopariae 1.5-2 part, Spica Prunellae 1-1.5 part, Radix Bupleuri 1-1.5 part, Radix Rehmanniae 1-1.5 part, Rhizoma Coptidis(processed with wine) 0.3-0.8 part, Pericarpium Citri Reticulatae Viride 0.5-1 part, Radix Astragali 1-1.5 part, Rhizoma Cyperi 0.3-0.8 part.
2, Ganfukang capsule according to claim 1 is characterized in that adding Radix Aucklandiae 0.3-0.5 part, Placenta Hominis 0.5-1 part, Radix Angelicae Sinensis 0.5-1 part, Radix Paeoniae Alba 0.5-1 part, Rhizoma Chuanxiong 0.3-0.8 part.
3, Ganfukang capsule according to claim 2 is characterized in that adding Radix Salviae Miltiorrhizae 0.5-1 part, Herba Cistanches 1-1.5 part, Radix Morindae Officinalis 1-1.5 part, Fructus Lycii 1-1.5 part, Fructus Ligustri Lucidi 1-1.5 part.
4, Ganfukang capsule according to claim 3 is characterized in that adding Herba Epimedii 1-1.5 part, Semen Allii Tuberosi 1-1.5 part, Cortex Eucommiae 0.5-0.8 part, Fructus Corni 0.5-0.8 part, Semen Cuscutae 1-1.5 part, Semen Ziziphi Spinosae 0.5-0.8 part, Fructus Schisandrae Chinensis 0.5-0.8 part.
5,, it is characterized in that capsule medicated powder is respectively to distinguish the flavor of ground product after the former medicated powder combination of medicine, the combination of former medicine or former medicine combination back by boiling the extract powder that the mode of carrying obtains according to the described Ganfukang capsule of one of claim 1-4.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910094627A CN101642516A (en) | 2009-06-15 | 2009-06-15 | Ganfukang capsule |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910094627A CN101642516A (en) | 2009-06-15 | 2009-06-15 | Ganfukang capsule |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101642516A true CN101642516A (en) | 2010-02-10 |
Family
ID=41654675
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200910094627A Pending CN101642516A (en) | 2009-06-15 | 2009-06-15 | Ganfukang capsule |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101642516A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102526618A (en) * | 2012-01-17 | 2012-07-04 | 张继成 | Improved hepatoprotective capsule |
CN102688451A (en) * | 2012-05-25 | 2012-09-26 | 王兴辉 | Chinese medicinal composition for treating alcoholic fatty liver |
CN104491533A (en) * | 2014-12-16 | 2015-04-08 | 河南中医学院 | Traditional Chinese medicine for preventing and treating duck virus hepatitis |
CN105148197A (en) * | 2015-10-09 | 2015-12-16 | 房经富 | Medicine for treating fatty liver caused by qi stagnation and blood stasis and preparation method of medicine |
CN105709007A (en) * | 2016-04-06 | 2016-06-29 | 雷玉河 | Traditional Chinese medicine composition as well as preparation method and application thereof |
-
2009
- 2009-06-15 CN CN200910094627A patent/CN101642516A/en active Pending
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102526618A (en) * | 2012-01-17 | 2012-07-04 | 张继成 | Improved hepatoprotective capsule |
CN102526618B (en) * | 2012-01-17 | 2014-01-22 | 张继成 | Improved hepatoprotective capsule |
CN102688451A (en) * | 2012-05-25 | 2012-09-26 | 王兴辉 | Chinese medicinal composition for treating alcoholic fatty liver |
CN102688451B (en) * | 2012-05-25 | 2013-08-21 | 王兴辉 | Chinese medicinal composition for treating alcoholic fatty liver |
CN104491533A (en) * | 2014-12-16 | 2015-04-08 | 河南中医学院 | Traditional Chinese medicine for preventing and treating duck virus hepatitis |
CN105148197A (en) * | 2015-10-09 | 2015-12-16 | 房经富 | Medicine for treating fatty liver caused by qi stagnation and blood stasis and preparation method of medicine |
CN105709007A (en) * | 2016-04-06 | 2016-06-29 | 雷玉河 | Traditional Chinese medicine composition as well as preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103341004B (en) | Chinese medicine composition for treating delayed menstrual cycle | |
CN101816776B (en) | Chinese medicinal composition for treating delayed menstrual cycle delayed menstrual cycledelayed menstrual cycle and preparation method thereof | |
CN101757561A (en) | Traditional Chinese medicine composition for treating chronic hepatitis and preparation method thereof | |
CN101642516A (en) | Ganfukang capsule | |
CN103611082A (en) | Weight-reducing traditional Chinese medicine composition | |
CN103341133A (en) | Traditional Chinese medicine composition for treating fatty liver and preparation method thereof | |
CN101642504B (en) | Capsule for reinforcing yin and clearing deficient heat | |
CN102988616B (en) | Chinese medicinal composition for treating anemia | |
CN105126045A (en) | Traditional Chinese medicinal composition for treating climacteric syndrome | |
CN104491802A (en) | Application of traditional Chinese medicine preparation in preparation of medicine for treating acute or chronic gastritis | |
CN104225166A (en) | Chinese medicine composition for treating amenorrhea and preparation method thereof | |
CN103977281A (en) | Traditional Chinese medicine composition for treating female endocrine disorders and preparation method thereof | |
CN104043077A (en) | Traditional Chinese medicine composition for tonifying qi and nourishing blood | |
CN103330837B (en) | Traditional Chinese medicine composition for curing osteoporosis of menopausal women | |
CN101642531B (en) | Capsule for strengthening spleen and lung and reducing blood sugar | |
CN104547623A (en) | Traditional Chinese medicine composition for reducing fats | |
CN102698178A (en) | Chinese medicinal composition for treating ulcerative colitis and preparation method thereof | |
CN103071079B (en) | Traditional Chinese medicinal composition for treating prurigo nodularis | |
CN104208640A (en) | Traditional Chinese medicine composition for treating delayed menstrual cycle | |
CN106581299B (en) | Traditional Chinese medicine composition for improving kidney qi deficiency of middle-aged and old people and application thereof | |
CN105381289A (en) | Pharmaceutical composition for treating abnormal menstruation | |
CN104983899A (en) | Traditional Chinese medicine composition for treating female deficiency of qi and blood | |
CN104274815A (en) | Traditional Chinese medicine composition for treating dysmenorrhea due to deficiency of vital energy and blood | |
CN104840806B (en) | Chinese medicinal preparation with anti-rheumatoid effect and production method thereof | |
CN102671042A (en) | Traditional Chinese medicinal composition for treating acne and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Open date: 20100210 |